Advanced Practice Midwife in Takoma Park, MD Accepting Medicare

4 Advanced Practice Midwife nurses found. Showing 1 - 4

Mrs. Kathleen Jo Peacock, CNM, RN Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 7301 Garland Ave, Takoma Park, MD 20912 Phone: 301-807-5605

Mairi Breen Rothman, CNM MSN Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 7301 Garland Ave, M.a.m.a.s., Inc., Takoma Park, MD 20912 Phone: 301-674-9976    Fax: 855-282-0727

Erin E Fulham, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 7301 Garland Ave, Takoma Park, MD 20912 Phone: 301-412-8800    Fax: 301-920-1107

Ms. Carina A. Ryder, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 7050 Carroll Ave, Suite 201, Takoma Park, MD 20912 Phone: 301-960-1155    Fax: 301-960-0097

News Archive

76 percent of Medicare beneficiaries believe the Medicare drug discount cards are a good idea

According to a survey commissioned by the Pharmacy Care Alliance, a large majority-76 percent-of Medicare beneficiaries without prescription drug coverage polled believe the Medicare drug discount cards are a good idea and will help them save money.

C3BS' new production facilities in Mont-Saint-Guibert granted GMP Certification

The Belgian biotechnology company Cardio3 BioSciences (C3BS), a leader in the discovery and development of regenerative and protective therapies for the treatment of cardiac diseases, today announces that it has been granted Good Manufacturing Practice (GMP) Certification for its new production facilities in Mont-Saint-Guibert.

High-titer convalescent plasma reduced COVID-19 symptom severity in green monkeys

As scientists scramble to find effective vaccines and antivirals for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a recent study published on the preprint server bioRxiv in October 2020 reports that the use of convalescent plasma to treat COVID-19 disease early in the course of the illness may be among the best available strategies at present.

USPTO allows Alnylam Pharmaceuticals' new claims from Woppmann et al. patent series

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today that the United States Patent Office (USPTO) has allowed a patent (Application No. 10/560,336) for the Woppmann et al. patent series, entitled "Double-stranded ribonucleic acid with increased effectiveness in an organism." The newly allowed patent includes 31 claims broadly covering compositions and methods, including pharmaceutical compositions, for small interfering RNAs (siRNAs), the molecules that mediate RNAi.

CPET measurement predicts mortality in patients following liver transplantation

Researchers from the U.K. determined that preoperative cardiopulmonary exercise testing (CPET) is a specific predictor of 90-day survival following liver transplantation.

Read more Medical News

› Verified 3 days ago